Plateletpheresis Donor Profile in a Tertiary Care Hospital

Authors

  • Rajni Bassi MD, Lecturer, Department of Transfusion Medicine, Government Medical College (Rajindra Hospital), Patiala (Punjab) India.
  • Thakur K. MD, Lecturer, Department of Transfusion Medicine, Government Medical College (Rajindra Hospital), Patiala (Punjab) India.
  • Bhardwaj K. MD, Professor & Head, Department of Transfusion Medicine, Government Medical College (Rajindra Hospital), Patiala (Punjab) India.

Keywords:

plateletpheresis, donor, apheresis, plateletpheresis session

Abstract

Meticulous donor-vigilance, superior technical personnel training and experienced transfusion medicine specialists supervision will make donor's experience more pleasant thereby giving a forward thrust to the noble vision of preparing a voluntary apheresis donor pool in India.

Downloads

Download data is not yet available.

References

Saran RK. Apheresis. In: Transfusion Medicine Technical Manual. New Delhi. Directorate General of Health Services, Ministry of Health & family Welfare, Government of India; 2003.p 229-43.

Dogra K, Fulzele P, Rout D, Chausasia R, Coshic P, Chaterjee K. Ind J Hematol & BT. 2016. Doi: 10. 1007/s12288-016- 0681-z.

Philip J, Sarkar RS, Pathak A. Adverse events associated with apheresis procedures: Incidence and relative frequency. Asian J Transfus Sc. 2013; 7(1): 37-41.

Winters JL. Complications of donor apheresis. J Clin Apher. 2006; 21:132–41. [PubMed]

Despotis GJ, Goodnough L, Dynis M, et al. Adverse events in platelet apheresis donors: A multivariate analysis in a hospital-based program. Vox Sang 1999;77:24-32.

Brasil. Agência Nacional de Vigilância Sanitária. Portaria MS no. 1.353, de 13.06.2011. 2011. [ Links ]

Fundação Hemominas. Manual de normas e procedimentos de atendimento ao doador. 2012. [ Links ].

Wollersheim J, Dautzenberg M, Griendt A, Sybesma B. Donor selection criteria to maximize double platelet products (DPP) by platelet apheresis. Transfus Apher Sci. 2006;34:179-86. [ Links ]

Yuan S, Ziman A, Smeltzer B, Lu Q, Goldfinger D. Moderate and severe adverse events associated with apheresis donations: incidences and risk factors. Transfusion (Paris). 2010;50:478-86. [ Links ]

Yuan S, Gornbein J, Smeltzer B, Ziman AF, Lu Q, Goldfinger D. Risk factors for acute, moderate to severe donor reactions associated with multicomponent apheresis collections. Transfusion (Paris). 2008;48:1213-9. [ Links ]

Tomita T, Takayanagi M, Kiwada K, Mieda A, Takahashi C, Hata T. Vasovagal reactions in apheresis donors. Transfusion (Paris). 2002; 42:1561-6. [ Links ]

Guo N, Wang J, Ness P, Yao F, Dong X, Bi X, et al. Demographics of apheresis platelet donors in five blood centers in China. Transfusion (Paris). 2012; 52:560-6. [ Links ]

Barbosa MH, Nunes da Silva KF, Coelho DQ, Tavares JL, Falcao da Cruz LF, Kanda MH. Rev Bras Hematol Hemoter. 2014; 36(3): 191-195.

Mercan D, Bastin G, Lambermont M, Duponz E. Importance of ionized m a g n e s i u m m e a s u re m e n t f o r monitoring of citrate-anticoagulated plateletpheresis. Transfusion (Paris). 1997;37:418-22. [ Links ]

Downloads

Published

30-06-2018

How to Cite

Rajni Bassi, Thakur K., & Bhardwaj K. (2018). Plateletpheresis Donor Profile in a Tertiary Care Hospital. GMC Patiala Journal of Research and Medical Education, 1(1), 28–32. Retrieved from https://jrme.gmcpatiala.edu.in/index.php/j/article/view/5

Issue

Section

Original Research Articles